Brief: Ipsen Q3 Revenue EUR 915 Million, Upgrades 2025 Outlook
Oct 22 (Reuters) - Ipsen SA IPN.PA: IPSEN Q3 REVENUE EUR 915 MILLION IPSEN SA - OUTLOOK 2025: TOTAL SALES GROWTH OF AROUND 10.0%(2) AT CER (PRIOR GUIDANCE GREATER THAN 7.0%) IPSEN SA - OUTLOOK 2025: CORE OPERATING MARGIN OF AROUND 35.0% OF TOTAL SALES (PRIOR GUIDANCE GREATER THAN 32.0%) Source text: ID:nGNECdcLS Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio